Back to Search
Start Over
Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis
- Source :
- Muscle & Nerve. 53:872-876
- Publication Year :
- 2015
- Publisher :
- Wiley, 2015.
-
Abstract
- Introduction Myasthenia gravis (MG) exacerbations may be treated with intravenous immunoglobulin (IVIg) or plasma exchange (PLEX), which have equivalent effectiveness. This cost-minimization analysis compared IVIg with PLEX for treatment of patients with MG exacerbation. Methods We combined the Ontario-based health cost data with clinical data from a randomized clinical trial. Analyses were undertaken from the perspective of a public healthcare insurer and from the perspective of a tertiary university hospital payer. Results PLEX was less costly than IVIg among patients with a body mass index (BMI) > 15.7 kg/m2, from the perspective of the public healthcare insurer (P 15.7 kg/m2, from the perspective of a public healthcare insurer. Muscle Nerve, 2015
- Subjects :
- medicine.medical_specialty
animal structures
Exacerbation
Physiology
law.invention
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Randomized controlled trial
law
hemic and lymphatic diseases
Physiology (medical)
Internal medicine
medicine
030212 general & internal medicine
Young adult
health care economics and organizations
biology
business.industry
fungi
medicine.disease
Myasthenia gravis
Surgery
Neuromuscular junction disease
Cost-minimization analysis
biology.protein
Neurology (clinical)
Antibody
business
Body mass index
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 0148639X
- Volume :
- 53
- Database :
- OpenAIRE
- Journal :
- Muscle & Nerve
- Accession number :
- edsair.doi...........7615cc58b609d17d39ce12cada15f205